Analysis

Vivos Therapeutics, Inc. (VVOS) Stock Analysis

Vivos Therapeutics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to VVOS.

websiteVVOS/analysis/VVOS

Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to VVOS.

Stock profile

Ticker

VVOS

Asset type

Stock

Market cap

$7.9M

Sector

Health Technology

Industry

Medical Specialties

Currency

USD

Ticker listings

Vivos Therapeutics, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • VVOS primary listing

Latest Vivos Therapeutics, Inc. news

Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Commo...

LITTLETON, Colo., June 22, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and healthcare services company ...

Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering

LITTLETON, Colo., June 11, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and healthcare services company ...

Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea a...

LITTLETON, Colo., June 10, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company ...

Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026

Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026

Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Sup...

Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing

Research sections

Valuation

Review valuation context for Vivos Therapeutics, Inc..

Future growth

Review future growth context for Vivos Therapeutics, Inc..

Past performance

Review past performance context for Vivos Therapeutics, Inc..

Financial health

Review financial health context for Vivos Therapeutics, Inc..

Dividend

Review dividend context for Vivos Therapeutics, Inc..

Management

Review management context for Vivos Therapeutics, Inc..

Ownership

Review ownership context for Vivos Therapeutics, Inc..

Other information

Review other information context for Vivos Therapeutics, Inc..

Community

Review community context for Vivos Therapeutics, Inc..